Home> Products> flavoxite 200 flavoxate

{ "products": [ { "_id": "6666c425acd19e1fd899115f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLAVOXITE 200 ", "description": "FLAVOXITE 200 \nFlavoxate (200mg)\nFlavoxite 200 contains Flavoxate, an oral medication used to treat urinary frequency, urgency, and incontinence. Here's a brief description:\n\nFlavoxite 200 (Flavoxate 200mg) is a medication prescribed to alleviate symptoms associated with urinary tract disorders such as frequent urination, urgency, and bladder instability. It works by relaxing the muscles in the bladder, reducing spasms, and improving control over urination. This medication is commonly used in conditions like overactive bladder and urinary incontinence. It is typically taken orally as directed by a healthcare professional. Common side effects may include dry mouth, dizziness, blurred vision, and constipation. It's important to follow your doctor's instructions and report any unusual symptoms while taking Flavoxite 200.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/flavoxite-200-133486\n\n\n\n\n\n\n", "price": 259.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "spasms", "control", "muscles", "urgency", "WhatsApp", "FLAVOXITE", "dry mouth", "dizziness", "conditions", "information", "sterispharma", "instructions", "constipation", "sterisonline", "blurred vision", "oral medication", "Flavoxate 200mg", "unusual symptoms", "brief description", "urinary frequency", "frequent urination", "overactive bladder", "bladder instability", "Common side effects", "urinary incontinence", "healthcare professional", "urinary tract disorders" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1649, "imageuri": "https://productimages.withfloats.com/actual/6666c4274b514c761a28e5a0.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666c4274b514c761a28e5a0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T09:15:17.711Z", "updatedon": "2024-06-27T11:36:58.583Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/flavoxite-200-/1649", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLAVOXITE 200 ", "category": "UROLOGYRANGE", "tags": [ "FLAVOXITE 200 mg", "Flavoxate 200mg price", "Flavoxate 200mg side effects", "Flavoxate 200mg dosage", "Flavoxate 200mg uses", "Flavoxate 200mg tablet", "", "flavoxate 200 mg tablet uses in hindi", "", "flavoxate tablet dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6979b09d927481ba212bc573", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tedizolid Phosphate 200 mg ", "description": "TEDIZOLINE 200 is a state-of-the-art pharmaceutical formulation containing Tedizolid Phosphate 200 mg, representing a significant advancement in the treatment of serious bacterial skin infections. This next-generation oxazolidinone antibiotic offers a powerful solution for patients battling acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant bacterial strains. Developed to address the growing challenge of antibiotic resistance, TEDIZOLINE 200 provides healthcare professionals with an effective therapeutic option when conventional antibiotics may fall short.\nThe active ingredient, Tedizolid Phosphate, functions as a prodrug that is rapidly converted in the body to its active form, tedizolid. This sophisticated mechanism ensures optimal bioavailability and targeted antibacterial action. Each tablet of TEDIZOLINE 200 delivers a precise 200 mg dose, carefully calibrated to provide maximum efficacy while minimizing the risk of adverse effects. The medication is available in convenient oral tablet form, offering flexibility in treatment administration and improving patient compliance compared to intravenous-only alternatives.\nClinical Applications and Therapeutic Uses\nTEDIZOLINE 200 is specifically indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible strains of various gram-positive bacteria. These infections include cellulitis, major cutaneous abscesses, and wound infections that require systemic antibiotic therapy. The medication demonstrates exceptional efficacy against problematic pathogens including Staphylococcus aureus (both methicillin-susceptible and methicillin-resistant strains), various Streptococcus species, and Enterococcus faecalis.\nHealthcare providers prescribe TEDIZOLINE 200 when patients present with complicated skin infections characterized by significant inflammation, purulent discharge, or systemic signs of infection such as fever and elevated white blood cell counts. The medication is particularly valuable in hospital settings where antibiotic-resistant organisms pose significant treatment challenges, though it is equally effective for outpatient management of appropriate cases.\nThe standard treatment duration with TEDIZOLINE 200 is notably shorter than many traditional antibiotics, typically requiring only six days of therapy. This abbreviated course represents a significant advantage, potentially improving patient adherence, reducing the risk of developing resistance, and minimizing healthcare costs while maintaining excellent clinical outcomes.\nKey Benefits and Therapeutic Advantages\nSuperior Antimicrobial Potency: TEDIZOLINE 200 exhibits exceptional bactericidal activity against resistant gram-positive organisms, making it a frontline weapon against infections that have failed to respond to first-line antibiotics. Its unique mechanism of action—inhibiting bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit—prevents bacteria from producing essential proteins necessary for survival and reproduction.\nShortened Treatment Duration: Unlike conventional antibiotics that may require ten to fourteen days of therapy, TEDIZOLINE 200 achieves comparable or superior outcomes with just six days of treatment. This condensed regimen reduces the pill burden for patients, improves treatment completion rates, and decreases the opportunity for resistance development.\nFlexible Administration Options: The medication offers both oral and intravenous formulations with nearly identical bioavailability, allowing seamless transitions between routes of administration. This flexibility enables early hospital discharge with continuation of oral therapy at home, reducing healthcare costs and improving patient comfort and quality of life.\nOnce-Daily Dosing Convenience: TEDIZOLINE 200's pharmacokinetic profile supports convenient once-daily administration, simplifying treatment schedules and enhancing patient compliance. The sustained therapeutic levels achieved with this dosing frequency ensure continuous antibacterial activity throughout the treatment course.\nReduced Drug Interaction Profile: Compared to its predecessor oxazolidinone antibiotics, TEDIZOLINE 200 demonstrates minimal interactions with dietary tyramine and requires less stringent dietary restrictions. Additionally, it exhibits reduced potential for serotonin syndrome, offering improved safety when used in patients taking certain antidepressants or other serotonergic medications.\nProven Clinical Efficacy: Extensive clinical trials have demonstrated that TEDIZOLINE 200 achieves cure rates comparable to or exceeding those of vancomycin and linezolid, the traditional gold standards for treating MRSA infections. These studies confirm both the non-inferiority and, in some parameters, the superiority of tedizolid phosphate in treating complicated skin infections.\nPotential Side Effects and Safety Considerations\nWhile TEDIZOLINE 200 is generally well-tolerated, patients and healthcare providers should be aware of potential adverse effects. The most commonly reported side effects include nausea, headache, diarrhea, and vomiting, which typically manifest as mild to moderate in severity and often resolve without intervention.\nGastrointestinal disturbances affect approximately five to ten percent of patients, with nausea being the most frequent complaint. Taking the medication with food may help minimize these symptoms without compromising absorption. Headaches occur in a similar percentage of patients and usually respond well to over-the-counter analgesics.\nMore serious but less common adverse effects include myelosuppression, manifesting as decreased blood cell counts. Although TEDIZOLINE 200 demonstrates less bone marrow suppression than older oxazolidinones, monitoring of complete blood counts is recommended for treatment courses extending beyond the standard six days or in patients with pre-existing hematologic conditions.\nPeripheral and optic neuropathy have been reported with prolonged oxazolidinone use, though the shorter treatment duration of TEDIZOLINE 200 substantially reduces this risk. Patients should report any vision changes, numbness, tingling, or weakness in extremities promptly to their healthcare provider.\nClostridium difficile-associated diarrhea can occur with virtually any antibiotic, including TEDIZOLINE 200. Patients experiencing severe, persistent, or bloody diarrhea during or following treatment should seek immediate medical attention.\nHypersensitivity reactions, though rare, may occur and can range from mild rash to severe anaphylaxis. Any signs of allergic reaction warrant immediate discontinuation and appropriate medical intervention.\nConclusion\nTEDIZOLINE 200 represents a significant therapeutic advancement in the management of acute bacterial skin and skin structure infections, particularly those involving antibiotic-resistant organisms. Its potent antimicrobial activity, convenient once-daily dosing, shortened treatment duration, and improved safety profile compared to earlier oxazolidinones make it an invaluable addition to the antimicrobial arsenal. The medication addresses critical unmet needs in infectious disease management, offering effective treatment options when traditional antibiotics prove insufficient.", "price": 1250.0, "discountamount": 375.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2288, "imageuri": "https://productimages.withfloats.com/actual/6979b0c4b75d7c0b79b08e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979b0c4b75d7c0b79b08e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:45:49.837Z", "updatedon": "2026-01-28T12:11:25Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tedizolid-phosphate-200-mg-/2288", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TEDIZOLINE 200", "category": "DERMATALOGY", "tags": [ "tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg uses", "tedizolid phosphate 200 mg dosage", "tedizolid phosphate tablets 200 mg price", "tedizolid phosphate 200 mg side effects", "tedizolid phosphate 200 mg brand name", "tedizolid phosphate 200 mg mechanism of action", "buy tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg prescription info", "tedizolid phosphate 200 mg tablet details", "tedizolid phosphate 200 mg for skin infection", "tedizolid phosphate 200 mg once daily tablet", "tedizolid phosphate 200 mg tablet working" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6979ab153e3091701b89e481", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Misoprostol Tablet 200 mcg", "description": "MISOPIRATE 200 is a pharmaceutical preparation containing Misoprostol 200 mcg, a synthetic prostaglandin E1 analogue that has revolutionized women's healthcare and gastrointestinal treatment protocols. This medication represents a critical therapeutic option in modern medicine, offering solutions for conditions ranging from gastric ulcer prevention to obstetric and gynecological applications. Each tablet of MISOPIRATE 200 is precisely formulated to deliver consistent therapeutic benefits while maintaining strict quality standards.Misoprostol, the active ingredient in MISOPIRATE 200, was initially developed for protecting the gastric lining but has since become indispensable in reproductive healthcare. The medication works by mimicking natural prostaglandins in the body, which are hormone-like substances that regulate various physiological processes including gastric acid secretion, cervical ripening, and uterine contractions.Mechanism of ActionMISOPIRATE 200 functions through multiple pathways depending on the clinical indication. In the gastrointestinal system, it reduces gastric acid secretion by directly inhibiting parietal cells in the stomach lining. Simultaneously, it enhances the production of protective mucus and bicarbonate, creating a defensive barrier against acid-induced damage. This dual action makes it exceptionally effective in preventing and treating peptic ulcers, particularly those induced by nonsteroidal anti-inflammatory drugs (NSAIDs).In obstetric and gynecological applications, MISOPIRATE 200 acts on prostaglandin receptors in the uterus and cervix. It causes the cervix to soften and dilate while stimulating rhythmic uterine contractions. These properties make it valuable for medical management of early pregnancy complications, labor induction, and postpartum hemorrhage prevention.Clinical Uses and ApplicationsGastric Protection: MISOPIRATE 200 serves as a prophylactic agent for individuals requiring long-term NSAID therapy who are at elevated risk for developing gastric or duodenal ulcers. Patients with rheumatoid arthritis, osteoarthritis, or chronic pain conditions who depend on NSAIDs benefit significantly from concurrent misoprostol therapy.Peptic Ulcer Treatment: The medication accelerates healing of existing gastric ulcers by reducing acid exposure and promoting mucosal regeneration. Treatment typically spans four to eight weeks, depending on ulcer severity and individual response.Medical Management of Early Pregnancy Loss: Under strict medical supervision, MISOPIRATE 200 is utilized for managing incomplete miscarriage or missed abortion, offering a non-surgical alternative that many women prefer for emotional and practical reasons.Labor Induction: In hospital settings, healthcare providers may use MISOPIRATE 200 to ripen the cervix and initiate labor when medically indicated, such as in cases of post-term pregnancy or maternal health concerns.Postpartum Hemorrhage Prevention: The medication's ability to promote uterine contractions makes it valuable in preventing excessive bleeding after childbirth, particularly in resource-limited settings.Key Benefits of MISOPIRATE 200Effective Gastric Protection: MISOPIRATE 200 provides superior protection against NSAID-induced gastric damage compared to many alternatives. Clinical studies demonstrate up to 80% reduction in serious gastrointestinal complications among high-risk patients using preventive misoprostol therapy.Non-Invasive Medical Option: For women facing early pregnancy complications, MISOPIRATE 200 offers a medical alternative to surgical procedures, preserving privacy, reducing healthcare costs, and eliminating surgical risks such as anesthesia complications or uterine perforation.Rapid Onset of Action: The medication demonstrates quick absorption and onset, with effects typically beginning within 30 minutes to two hours, allowing for predictable therapeutic outcomes.Cost-Effectiveness: Compared to surgical interventions or hospitalization for complications, MISOPIRATE 200 represents an economical treatment option, making essential healthcare more accessible to diverse populations.Versatile Clinical Applications: The medication's multiple therapeutic uses make it a valuable tool across different medical specialties, from gastroenterology to obstetrics.Stable Formulation: MISOPIRATE 200 maintains stability across various storage conditions, improving accessibility in regions with limited refrigeration infrastructure.Potential Side Effects and Adverse ReactionsWhile MISOPIRATE 200 is generally well-tolerated, users should be aware of possible side effects:Gastrointestinal Disturbances: Diarrhea occurs in approximately 15-40% of patients, typically mild and self-limiting. Abdominal cramping, nausea, and flatulence are also common, particularly during initial treatment phases.Uterine Effects: Women of reproductive age may experience menstrual irregularities, heavier menstrual flow, or intermenstrual spotting. Uterine cramping is expected when the medication is used for obstetric purposes.Vascular Symptoms: Some patients report headaches, dizziness, or hot flashes, though these are generally transient and mild in nature.Allergic Reactions: Though rare, hypersensitivity reactions including skin rashes, itching, or more serious anaphylactic responses can occur and require immediate medical attention.Serious Complications: When used inappropriately for pregnancy termination outside medical supervision, serious complications including incomplete abortion, severe bleeding, infection, or rupture can occur. This underscores the critical importance of medical oversight.Important Precautions and ContraindicationsMISOPIRATE 200 is absolutely contraindicated during pregnancy when the intention is to continue the pregnancy, as it can cause miscarriage or severe fetal abnormalities. Women of childbearing potential must use reliable contraception during treatment. The medication should not be used by individuals with known allergy to prostaglandins or those with inflammatory bowel disease without careful medical evaluation.Patients with cardiovascular disease, cerebrovascular conditions, or poorly controlled hypertension require careful monitoring when using MISOPIRATE 200. The medication may interact with antacids containing magnesium, potentially exacerbating diarrhea.Dosage and Administration GuidelinesDosing of MISOPIRATE 200 varies significantly based on the clinical indication. For gastric protection, typical regimens involve 200 mcg taken two to four times daily with meals. For obstetric uses, dosing protocols are highly specific and must be determined by qualified healthcare providers based on individual circumstances, gestational age, and medical history.The medication should be taken with food to minimize gastrointestinal side effects. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed otherwise by a healthcare provider.ConclusionMISOPIRATE 200 represents a significant therapeutic advancement in both gastroenterology and reproductive healthcare. Its dual capacity to protect the gastric mucosa and influence uterine function makes it an invaluable medication across multiple clinical scenarios. The proven efficacy in preventing NSAID-induced ulcers has prevented countless cases of serious gastrointestinal bleeding, while its role in women's healthcare has expanded access to safe, effective medical management options.", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2287, "imageuri": "https://productimages.withfloats.com/actual/6979ab1bad683d72f6cf0b98.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979ab1bad683d72f6cf0b98.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:22:13.304Z", "updatedon": "2026-01-28T12:41:00.351Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/misoprostol-tablet-200-mcg/2287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MISOPIRATE 200", "category": "GYANECOLOGYRANGE", "tags": [ "misoprostol tablet 200 mcg uses", "misoprostol 200 mcg tablet dosage", "misoprostol 200 mcg tablet benefits", "misoprostol tablet 200 mcg composition", "misoprostol 200 mcg tablet how it works", "misoprostol tablet 200 mcg side effects", "misoprostol 200 mcg tablet mechanism of action", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet storage instructions", "misoprostol 200 mcg tablet for gastric protection", "misoprostol 200 mcg tablet prostaglandin analog", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet administration guide", "misoprostol tablet 200 mcg patient information" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-01-02T09:51:07.877Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "Gynaecology", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69400387893a9153e4bd58a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Terbinafine and Itraconazole Tablets 250/200mg", "description": "CONARIS T200 is a potent antifungal combination tablet containing Terbinafine 250 mg and Itraconazole 200 mg, formulated to provide effective treatment for various fungal infections. Fungal infections of the skin, nails, and hair are common in India due to the hot and humid climate. These infections can cause itching, redness, scaling, and discomfort, affecting daily life and confidence.\n\nBy combining two powerful antifungal agents, CONARIS T200 targets fungal infections effectively, providing faster relief and improved recovery compared to monotherapy. Terbinafine works by inhibiting fungal cell growth, while Itraconazole disrupts fungal cell membrane formation, resulting in a comprehensive antifungal effect.\n\nUses\n\nCONARIS T200 is primarily prescribed for the management of:\n\nDermatophytosis (Ringworm, Tinea Infections)\nTreats fungal infections affecting skin, nails, and scalp.\n\nOnychomycosis (Fungal Nail Infection)\nHelps in eliminating nail fungus and promotes healthy nail growth.\n\nCandidiasis (Yeast Infections)\nEffective against mucocutaneous and superficial candidal infections.\n\nOther Superficial Fungal Infections\nUseful in treating skin infections caused by dermatophytes, yeasts, and other fungi.\n\nThis combination is particularly beneficial for chronic, resistant, or recurrent fungal infections.\n\nBenefits\n1. Broad-Spectrum Antifungal Activity\n\nThe dual action of Terbinafine and Itraconazole ensures effectiveness against a wide range of fungi, providing comprehensive treatment.\n\n2. Faster Symptom Relief\n\nPatients experience reduced itching, redness, scaling, and discomfort sooner than with single antifungal therapy.\n\n3. Promotes Healing\n\nSupports the restoration of healthy skin and nails, improving appearance and comfort.\n\n4. Reduces Recurrence\n\nThe combination therapy helps prevent fungal infections from returning, especially in chronic or resistant cases.\n\n5. Convenient Oral Administration\n\nOnce- or twice-daily tablet dosing improves patient compliance compared to topical treatments.\n\n6. Suitable for Adults\n\nFormulated for adult patients suffering from persistent fungal infections that require systemic therapy.\n\nDosage\n\nThe recommended dose of CONARIS T200 is usually one tablet once daily, or as directed by a physician.\n\nDuration of therapy depends on the type and severity of infection:\n\nSkin infections: Typically 2–4 weeks\n\nNail infections: May require 6–12 weeks or longer for full recovery\n\nImportant Instructions:\n\nSwallow the tablet whole with water.\n\nTake the medicine after food to reduce stomach upset.\n\nDo not skip doses and complete the full course even if symptoms improve.\n\nAlways follow the prescribing doctor’s instructions to ensure optimal results.\n\nSide Effects\n\nCONARIS T200 is generally well-tolerated, but some patients may experience mild side effects:\n\nNausea and vomiting\n\nStomach discomfort or indigestion\n\nHeadache\n\nDizziness\n\nSerious but Rare Side Effects\n\nLiver function disturbances\n\nAllergic reactions such as rash or swelling\n\nSevere gastrointestinal discomfort\n\nIf any unusual or severe symptoms appear, consult a healthcare professional immediately.\n\nPrecautions and Warning\n\nLiver and Kidney Disorders: Use with caution; liver function tests may be recommended during therapy.\n\nPregnancy and Breastfeeding: Consult your doctor before use; safety has not been fully established.\n\nDrug Interactions: Inform your doctor about other medications, particularly antacids, anticoagulants, or statins.\n\nAllergy: Avoid if allergic to Terbinafine, Itraconazole, or any other ingredient in the tablet.\n\nAlcohol Consumption: Limit alcohol intake, as it may increase the risk of liver-related side effects.\n\nConclusion\n\nCONARIS T200 (Terbinafine 250 mg + Itraconazole 200 mg) is an effective and trusted antifungal combination for the treatment of a variety of superficial and chronic fungal infections. By targeting fungi through dual mechanisms, it provides faster relief, promotes healing, and helps prevent recurrence. With proper dosing, adherence to medical advice, and monitoring for side effects, CONARIS T200 offers a comprehensive solution for adults dealing with persistent fungal infections, helping restore healthy skin, nails, and overall comfort.", "price": 204.0, "discountamount": 61.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2247, "imageuri": "https://productimages.withfloats.com/actual/69400389f34633ae3de3f8f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/69400389f34633ae3de3f8f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-15T12:48:07.707Z", "updatedon": "2025-12-16T05:48:08.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/terbinafine-and-itraconazole-tablets-250-200mg/2247", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONARIS T200", "category": "DERMATALOGY", "tags": [ "terbinafine and itraconazole tablets", "terbinafine and itraconazole", "terbinafine and itraconazole combination", "terbinafine and itraconazole together", "Fungal infections of the skin", "helping restore healthy skin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c2a25e5aca52da7cb29f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Favipiravir 200mg", "description": "Favipiravir 200mg is an antiviral medication widely used to treat viral infections, particularly those caused by RNA viruses. It has gained significant attention in recent years as a promising therapeutic agent, especially during viral outbreaks such as influenza and more recently, COVID-19. This detailed description covers the product overview, its uses, key benefits, potential side effects, and a concluding summary to help users better understand Favipiravir 200mg.\n\nProduct Description\nFavipiravir belongs to a class of antiviral drugs that inhibit the replication of RNA viruses by targeting viral RNA-dependent RNA polymerase—an enzyme vital for viral replication. The 200mg dosage formulation is designed for oral administration and is typically available as film-coated tablets. The drug works by interfering with the viral genome synthesis process, thereby limiting the ability of viruses to multiply and spread in the body.\n\nOriginally developed and approved in Japan for the treatment of novel influenza strains, Favipiravir has since been explored and authorized in multiple countries for off-label or emergency use against other viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nUses of Favipiravir 200mg\nFavipiravir is primarily used as an antiviral treatment for infections caused by RNA viruses. Its key applications include:\n\nInfluenza Treatment: Favipiravir is effective against various strains of influenza viruses, especially when other antiviral medications prove less effective due to resistance or outbreak severity.\n\nCOVID-19 Management: During the COVID-19 pandemic, Favipiravir was rapidly adopted as part of many treatment protocols globally. It is used to manage mild to moderate COVID-19 cases by reducing viral load and accelerating recovery time.\n\nEmerging Viral Diseases: Favipiravir’s broad-spectrum antiviral activity makes it a potential treatment for other emerging RNA virus outbreaks, including Ebola, Lassa fever, and other viral hemorrhagic fevers.\n\nThe drug is typically prescribed by healthcare professionals after confirmed diagnosis and assessment of viral infection severity. Treatment duration and dosage depend on the specific infection and patient profile.\n\nKey Benefits of Favipiravir 200mg\nFavipiravir offers several important benefits that contribute to its growing role in viral infection management:\n\nBroad-Spectrum Antiviral Activity: Favipiravir targets a wide array of RNA viruses, making it versatile for treating multiple infections beyond influenza.\n\nOral Administration: Its oral tablet form facilitates ease of use in outpatient settings, reducing the burden on hospital resources and enabling home-based treatment.\n\nRapid Viral Load Reduction: Clinical studies indicate that Favipiravir can significantly decrease viral replication rates, thereby reducing the duration and severity of symptoms.\n\nPotential to Limit Disease Progression: Early treatment with Favipiravir may prevent progression to severe disease stages, especially in viral respiratory infections such as COVID-19.\n\nEmergency and Compassionate Use Flexibility: During health crises, Favipiravir has been approved under emergency use protocols, making it accessible when other options are limited.\n\nPotential Side Effects of Favipiravir 200mg\nWhile Favipiravir is generally well-tolerated, users should be aware of possible side effects. Reported adverse effects range from mild to moderate in severity and often resolve after treatment completion:\n\nGastrointestinal Disturbances: Nausea, vomiting, diarrhea, and abdominal discomfort may occur but are usually transient.\n\nElevated Liver Enzymes: Temporary increases in liver function tests have been reported, necessitating monitoring especially in patients with preexisting liver conditions.\n\nElevated Uric Acid Levels: Favipiravir can cause hyperuricemia; monitoring uric acid levels is advisable during treatment.\n\nHypersensitivity Reactions: Rare cases of allergic reactions, including rash, itching, or swelling, have been documented.\n\nTeratogenicity and Contraindications in Pregnancy: Favipiravir is contraindicated in pregnant women or those planning pregnancy due to potential risks of fetal harm observed in animal studies.\n\nPatients should inform their healthcare providers of all preexisting conditions and concomitant medications to avoid drug interactions and complications. Routine blood tests may be conducted to monitor liver function and uric acid levels during therapy.\n\nConclusion\nFavipiravir 200mg serves as a vital antiviral agent with broad-spectrum activity against RNA viruses, playing a significant role in managing viral infections like influenza and COVID-19. Its ability to reduce viral replication rapidly and its oral administration mode make it a convenient and effective option, particularly in outpatient or emergency settings. While side effects are generally manageable, careful patient monitoring ensures safe use, especially in vulnerable populations.\n\nAs viral epidemics and pandemics continue to challenge global health, Favipiravir remains an important therapeutic tool, helping to curb disease progression and improve patient outcomes. Consulting a healthcare professional before starting Favipiravir treatment is essential to determine appropriateness, dosage, and duration based on individual health status and specific viral infection.", "price": 1786.0, "discountamount": 536.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2238, "imageuri": "https://productimages.withfloats.com/actual/6937c2a56743e47449a24df1.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c2a56743e47449a24df1.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T06:33:06.62Z", "updatedon": "2026-01-29T06:00:25.24Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/favipiravir-200mg/2238", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FAVIPRIVE 200", "category": "GENERAL RANGE", "tags": [ "Favipiravir 200mg", "RNA viruses", "Favipiravir 200mg", "COVID-19", "respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Favipiravir targets a wide array of RNA viruses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcad9fed2e6fda11c49da5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate IP 6 mcg & Budesonide IP 200 mcg", "description": "Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) often require a dual-acting therapy that can provide both rapid symptom relief and long-term inflammation control.\nBUDESHINE F 200 is a scientifically advanced inhalation therapy that combines Formoterol Fumarate (a long-acting bronchodilator) and Budesonide (a corticosteroid). This dual formulation is designed to target the root causes of breathing difficulties—airway inflammation and bronchoconstriction—providing patients with improved lung function, reduced symptoms, and better quality of life.\nComposition\nEach dose of BUDESHINE F 200 contains:\nFormoterol Fumarate – A long-acting β2-adrenergic agonist (LABA)\nBudesonide 200 mcg – An inhaled corticosteroid (ICS)\nMechanism of Action\nFormoterol Fumarate\nActs as a long-acting bronchodilator.\nStimulates β2-receptors in the airway smooth muscle, leading to relaxation and widening of bronchial passages.\nProvides rapid onset (within minutes) and sustained action for up to 12 hours, ensuring long-lasting relief from breathlessness and wheezing.\nBudesonide\nA potent corticosteroid with powerful anti-inflammatory properties.\nReduces swelling, irritation, and mucus production in the airways.\nHelps prevent asthma attacks and COPD exacerbations when used regularly.\n Together, this combination ensures symptom relief, prevention of flare-ups, and long-term disease control.\nTherapeutic Indications\nBUDESHINE F 200 is prescribed for:\nAsthma – maintenance therapy for patients requiring both a bronchodilator and corticosteroid.\nChronic Obstructive Pulmonary Disease (COPD) – including chronic bronchitis and emphysema.\nPrevention of Exercise-Induced Bronchospasm (when used as maintenance therapy).", "price": 195.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2186, "imageuri": "https://productimages.withfloats.com/actual/68fccd49565ed08cb9c69f49.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fccd49565ed08cb9c69f49.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T10:59:43.46Z", "updatedon": "2025-12-01T12:31:27.634Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-200-mcg/2186", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 200 CAP", "category": "ASTHMA RANGE", "tags": [ "Respiratory", "asthma", "Clopidogrel and Atorvastatin combination brands", "chronic obstructive pulmonary disease (COPD)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cefpodoxime Proxetil Tablets IP 200 mg", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 173.0, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/69294e18b456de02c99ff75f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69294e18b456de02c99ff75f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2026-02-13T07:43:02.114Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefpodoxime-proxetil-tablets-ip-200-mg/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEPHODOXIAA 200", "category": "GENERAL RANGE", "tags": [ "Cefpodoxime Proxetil 200 mg", "bacterial infections", "Broad-spectrum antibacterial activity", "CEPHODOXIAA 200", "urinary tract infections" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6863d70eaf0c9d1aa0c2d3e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 200", "description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "24 hours", "increased risk", "drugs interact", "antiviral medications", "recommended dose", "airways open", "reduce inflammation", "acute asthma", "asthma attacks", "severe asthma", "copd attacks", "inhaler consistently", "optimal results", "breathing comfort", "longacting bronchodilation", "antiinflammatory power", "inhaled corticosteroids", "vilanterol antifungal", "tricyclic antidepressants", "taking betablockers", "prescribed inform", "tuberculosis rinse", "headache hoarseness", "initial phase", "generally welltolerated", "fluticatone vilo 200", "exercise capacity", "emphysema reduces", "chronic bronchitis", "relaxing muscles", "rescue medicine", "vilanterol relaxes", "prevent symptoms", "specially formulated", "vilanterol 25 mcg", "vilanterol powder", "rare effects", "ketoconazole ritonavir", "healthcare provider", "therapy common", "potent corticosteroid", "fluticasone furoate", "side effects", "lung function", "vilanterol fluticasone furoate", "copd exacerbations improves", "inhalation fluticasone furoate", "lung function quality", "fixeddose inhalation powder", "increase corticosteroid levels", "fastacting inhaler inform", "combination inhalation therapy", "side effects consult", "frequent side effects", "inhalation longterm treatment", "healthcare providers guidance", "ritonavir itraconazole leading", "highly effective corticosteroid", "effective oncedaily treatment", "heart rhythm disturbances", "strong cyp3a4 inhibitors", "hypokalemia mao inhibitors", "atenolol propranolol diuretics", "breastfeeding drug interactions", "pregnant planning pregnancy", "avoid oral thrush", "sore throat cough", "adolescents maintenance treatment", "longterm maintenance treatment", "prescription combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2140, "imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:39:42.59Z", "updatedon": "2025-12-10T06:16:31.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation", "chronic obstructive pulmonary disease", "lung function", "Fluticasone Furoate and Vilanterol Powder", "emphysema." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }